Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Acceler8 Ventures PLC Capital/Financing Update 2026

Apr 21, 2026

10413_rns_2026-04-21_3e3667ab-03e9-4972-8a13-219b4b67a941.html

Capital/Financing Update

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2076B

Acceler8 Ventures PLC

21 April 2026

21 April 2026

ACCELER8 VENTURES PLC

Results of CLN fundraise

Acceler8 Ventures Plc (LSE: AC8, "AC8" or the "Company"), the Main Market listed acquisition company, announces that, further to the announcement made on 8 April 2026 ("CLN Announcement"), AC8 has successfully secured funding commitments of £1,000,000 through the proposed issue of unsecured Convertible Loan Notes ("2026 CLNs").

The 2026 CLNs will be issued to incoming investors, in accordance with the terms set out in the CLN Announcement, with the proceeds from the 2026 CLNs to be used to support the Company's near term working capital requirements, as described in the CLN Announcement.

The issuance of the 2026 CLNs remains conditional on approval by shareholders of the Company of the requisite resolutions at a general meeting of the Company, as set out in the CLN Announcement.

Enquiries:

Acceler8 Ventures Plc David Williams C/o Tessera Investment Management Limited
Tessera Investment Management Limited

(Financial Adviser to AC8)
Tony Morris

Katie Long

James Strang
Tel: 07742 189145

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ROIURSKRNOUSUAR